This document discusses BLQ Checkpoint, a peer-based community service that provides rapid HIV testing, STI testing, counseling, and linkage to care. Key services discussed include rapid HIV testing using finger sticks by nurses, peer counseling before and after testing, and possible implementation of HCV and syphilis testing. The document also outlines the need for such services in Italy, where an estimated 150,000 people are living with HIV but about a quarter are undiagnosed. It notes barriers like stigma, lack of harm reduction policies for men who have sex with men, and lack of reliable data on at-risk populations that contribute to the ongoing HIV epidemic in Italy.
A brief overview/history of the HIV-related work I've done since 2004, for a panel discussion on HIV in the USA and abroad for the 24th Annual Minority Health Conference of the student organization Public Health Students of African Descent (PHSAD). Conference title - "Health, Poverty, and Inequality: Innovative Approaches to Improving Global Health". Presented 23 March 2010.
Join us as we discuss best practices for integrating HIV prevention (e.g. HIV testing, PrEP and linkage to care) into primary care within the context of enhancing clinical workforce development.
Panelists:
• Marwan Haddad, MD, MPH, AAHIVS, Medical Director, Center for Key Populations, Community Health Center, Inc.
• Jeannie McIntosh, APRN, FNP-C, AAHIVS, Family Nurse Practitioner, Center for Key Populations, Community Health Center, Inc.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This workshop is designed to talk about the impact of STDs on youth under the age of 25. This workshop will discuss the importance of sexual health screenings, partner management, and current data around STD morbidity rates. We will also talk about current STD clinical recommendations for the treatment of gonorrhea, chlamydia, and syphilis. Participants will engage in an interactive activity where they will sharpen their skills on effective partner management strategies.
An overview of the issues related to the criminalisation of HIV exposure and transmission in Australia.
This presentation was given by Sally Cameron, HIV Education and Health Promotion Officer with AFAO, at the AFAO National HIV Forum, 17 October 2014.
Global Medical Cures™ | HIV TESTING IN USA
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Health eNav: Developing a System of Digital HIV Care Navigation in San FranciscoYTH
Health eNavigation or Health eNav is an innovative HIV care navigation model being tested by the San Francisco Department of Public Health. This session will explain how Health eNav will utilize comprehensive digital navigation strategies including text-messaging, social media and geo-spatial platforms to meet youth where they are. Health eNav will also extend the system of tailored, personalized support outside traditional hours of operation. Health eNav harnesses the promise of mhealth within the world’s most complex public health department to develop a system of digital HIV care navigation. Health eNav is your digital companion to help guide you through important decisions, whenever, wherever and however you want it. Health eNav will also extend the system of tailored, personalized support outside traditional work hours. Connection is health. Health eNav is bringing connection to those who need it most to improve health outcomes to create and connect a healthier San Francisco.
Where's the hope? Dialogues for Solidarity - Session 4ReShape
This session explored current work experiences in HIV care from a specialist point of view and looked at how current conditions impacted related care providers. Reflecting on the changing nature of HIV care and the changing needs of people living with HIV, the session examined the policy implications of a fragmented system and the patients' perspective on HIV care.
The Care Providers session was expected to lay the groundwork for a future session on the failing Health Economy as a leading issue.
A brief overview/history of the HIV-related work I've done since 2004, for a panel discussion on HIV in the USA and abroad for the 24th Annual Minority Health Conference of the student organization Public Health Students of African Descent (PHSAD). Conference title - "Health, Poverty, and Inequality: Innovative Approaches to Improving Global Health". Presented 23 March 2010.
Join us as we discuss best practices for integrating HIV prevention (e.g. HIV testing, PrEP and linkage to care) into primary care within the context of enhancing clinical workforce development.
Panelists:
• Marwan Haddad, MD, MPH, AAHIVS, Medical Director, Center for Key Populations, Community Health Center, Inc.
• Jeannie McIntosh, APRN, FNP-C, AAHIVS, Family Nurse Practitioner, Center for Key Populations, Community Health Center, Inc.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This workshop is designed to talk about the impact of STDs on youth under the age of 25. This workshop will discuss the importance of sexual health screenings, partner management, and current data around STD morbidity rates. We will also talk about current STD clinical recommendations for the treatment of gonorrhea, chlamydia, and syphilis. Participants will engage in an interactive activity where they will sharpen their skills on effective partner management strategies.
An overview of the issues related to the criminalisation of HIV exposure and transmission in Australia.
This presentation was given by Sally Cameron, HIV Education and Health Promotion Officer with AFAO, at the AFAO National HIV Forum, 17 October 2014.
Global Medical Cures™ | HIV TESTING IN USA
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Health eNav: Developing a System of Digital HIV Care Navigation in San FranciscoYTH
Health eNavigation or Health eNav is an innovative HIV care navigation model being tested by the San Francisco Department of Public Health. This session will explain how Health eNav will utilize comprehensive digital navigation strategies including text-messaging, social media and geo-spatial platforms to meet youth where they are. Health eNav will also extend the system of tailored, personalized support outside traditional hours of operation. Health eNav harnesses the promise of mhealth within the world’s most complex public health department to develop a system of digital HIV care navigation. Health eNav is your digital companion to help guide you through important decisions, whenever, wherever and however you want it. Health eNav will also extend the system of tailored, personalized support outside traditional work hours. Connection is health. Health eNav is bringing connection to those who need it most to improve health outcomes to create and connect a healthier San Francisco.
Where's the hope? Dialogues for Solidarity - Session 4ReShape
This session explored current work experiences in HIV care from a specialist point of view and looked at how current conditions impacted related care providers. Reflecting on the changing nature of HIV care and the changing needs of people living with HIV, the session examined the policy implications of a fragmented system and the patients' perspective on HIV care.
The Care Providers session was expected to lay the groundwork for a future session on the failing Health Economy as a leading issue.
Where's the hope? Dialogues for Solidarity - Session 1ReShape
Session 1: GIPA Principles for the 21st Century with guest, Sean Strub, Sero Project, USA
Where’s the Hope?, a year-long series of dialogues for solidarity, is coordinated by ReShape, an independent London-based think tank formed to respond to the ongoing crisis in sexual health.
Working together, activists and organisers will share their experiences and explore new op- portunities to address explore chronic obstacles to successful organising in HIV, HCV and re- lated sexual and mental health concerns. Emerging advocates and organisers are especially welcome.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
3. BLQ checkpoint Services
Peer - Community based
Rapid HIV test (finger stick – nurses)
Peer counselling (before+after)
STI (HCV, syphilis)
PEP, TASP, PrEP
Possible implementation: HCV and syphilis
4. blq checkpoint
characteristics and methodology
People with reactive HIV test: counselling and clinic
– Groups
– Workshops
• People tested negative
counselling on safer sex, stigma towards HIV-positive
Repeat test every 6-12 months.
5. blq checkpoint
characteristics and methodology
People with reactive HIV test: counselling and clinic
– Groups
– Workshops
• People tested negative
counselling on safer sex, stigma towards HIV-positive
Repeat test every 6-12 months.
6. Plus services
what we offer now
Positive gay sex
Positive Line
HIV Task Force
8. Plus Onlus
Why 10 years for a Checkpoint
In Italy we fight HIV in at least 2 directions,
on the social level
9. Plus Onlus
Why 10 years for a Checkpoint
bureaucracy and the inaction of public
health
COA estimate 150,000 HIV+ in Italy, about a quarter of them don't know they're
HIV+; no effective campaign to bring out the underworld;
Public campaigns: generalist and inefficient (or harmful)
No policy of harm reduction for MSM
We have few reliable data on the MSM population, only estimates from incidence;
We don't have prevalence studies on most at risk populations;
We don't know how many Elisa test are provided in Italy;
10. Plus Onlus
Stigma and discrimination
within the gay community and public health
“gay” and “HIV” not in the same sentence;
No gay sex in campaigns vs HIV;
PEP – PrEP what? (condoms are cheaper than drugs);
Difficult to talk about sexual practices;
HIV+ shame; (double if gay)
Health care personnel discriminates;
Better not to know;
12. Late presenters among new
diagnoses, 2012
Heterosexual
MSM
IDU
Blood
Per cent
Vert. Transm.
Other
Use of antiretroviral therapy before AIDS by way of transmission
13. NEW DIAGNOSIS ER
New diagnoses of HIV infection by mode of transmission and province of residence,
Emilia-Romagna, from 2006-2011. (percentages)
source: LO STATO DELL’INFEZIONE DA HIV/AIDS IN EMILIA-ROMAGNA Aggiornamento sull’epidemia al 31/12/2011
Hi everybodies
First of all I have to ask you “sorry” for my English because is really not very good.
My name is Sandro Mattioli. I chair Plus that is an LGBT HIV+ association, most of our associated are MSM HIV+, we're based in Bologna, Italy.
Bryan asked me to tell you about our Checkpoint and some problems that we had to manage in our city and in our region.
And because Bryan told us to stay in the 10 minutes, and this is my first English presentation, I decided to write some notes so that I can read.
First of all I have to tell that our checkpoint isn't open yet. This is what is planned.
As second think I want to tell you that or checkpoint will work keeping in mind 2 central concepts: peer and community based, because they're the true innovations for Italy (so maybe you can imagine the late that we have).
I think that our checkpoint will not be much different from the others.
We'll provide rapid HIV test (finger stick) with peer counselling before and after each test. and we hope that, thanks to the fact that we're an association, not a hospital, not an ambulatory, will make easier for MSM people to talk frankly about sexual practices, safer sex, risk perception, and stigma, of course, that's play an important role.
The test will be anonymous, confidential and for free; it will be done by nurses, kindly offered by the local health authority.
We'll also provide information on STI (expecially HCV and syphilis that are very common in the community and, as soon as possibile after the openig, we plan to provide test for this 2 STI.
Of course we also give information about these 3 new prevention techniques
In case of reactive test, the person will receive counseling and an appointment with an infectious disease physician for confirmation of the result. In Italy it is mandatory confirmation by western blot test.
We plan to activate support group for HIV+ people, and specific workshops for MSM living with HIV.
In case of negative results, we'll provide counselling on risk perception, safer sex and stigma towards HIV-positive people.
In case of reactive test, the person will receive counseling and an appointment with an infectious disease physician for confirmation of the result. In Italy it is mandatory confirmation by western blot test.
We plan to activate support group for HIV+ people, and specific workshops for MSM living with HIV.
In case of negative results, we'll provide counselling on risk perception, safer sex and stigma towards HIV-positive people.
At the moment, the association provides positive gay sex: not for real I'm afraid, it's a booklet, a sexual guide for positive MSM (Giulio's been a very good performer, I'm very happy to punish him, to leave me alone here).
and positive line, twice a week (Wednesdays and Sundays from 6 to 10 pm).
We also have a group of volunteers who make information on HIV, safer sex, stigma and so on in gay bars, clubs, and so on... so called
We plan to open the BLQ Checkpoint at the beginning of 2015.
Thanks to the fact that, a couple of months ago, we finally signed an agreement with the Municipality and the local health authority that give us the permission to open and manage the first community based Checkpoint of Italy.
The point, now, is that we have to renovate our place, that, as you can see, is quite destoyed, at a cost of around € 100,000.
In case, we accept checks
COA estimate 150,000 HIV+ in Italy, about a quarter of them don't know they're HIV+; no effective campaign to bring out the underworld;
Public campaigns: generalist and inefficient (when not harmful) / For example in Italy after 30 years of epidemic, this is our idea of effective prevention. After all, we're a country where a pope said that condoms are not the answer to fight HIV. And as a matter of fact, you'll not see condoms, or anything else to reminde us that HIV is an STI: no sex we're catholics.
No policy of harm reduction for MSM
We have few reliable data on the MSM population, only estimates from incidence;
We don't have prevalence studies on most at risk populations;
We don't know how many Elisa test are provided in Italy;
- Many gay organizations and leaders of the LGBT movement don't want to read the words “gay” and “HIV” in the same sentence;
- They don't want that gay sex is used for campaigns against HIV; in 2 words: no national policies and programming. This was a national campaign of the biggest gay association, and this was my answer... many gay leaders accused me of pornografy and discrimination for this immage.
- The homosexual community is left to the Middle Ages, it is very difficult to talk about PEP or PrEP (because condoms are cheaper than drugs);
- It is difficult to talk about sexual practices in Italy except to be a doctor and speak Latin so that no one understands;
- Being HIV positive is still a shame; Being gay and HIV-positive is a double shame for both the general population and for the gay community;
- Health care personnel (outside clinics of infectious diseases) often discriminates people living with HIV; This is an acceptance document to an emergency room of a public hospital, the guy walked to corridors with this red text
- Even today, many gays prefer not to know, at least a quarter of the msm population has never done an hiv test in life;
In fact, our first work as Plus has been on the stigma. We try
just to attack one of the most famous (and worse) ministerial campaigns
This chart, which always leaves me speechless: refers to people who have made use of ARV therapy before the diagnosis of AIDS.
Not HIV, attention to AIDS.
Official data of the COA. Look at the light blue bar of the MSM, this is a good answer for those who argue that we are a population that is already alerted and carefully ... all lie
This is a study of our regional center of control. New diagnoses divided by province and transmission. The yellow bar indicates the new diagnoses among MSM and the green one are the heterosexual males. AS you can see in Bologna we have more new diagnoses among MSM than among Heterosexual males, as a percentage of course.
These are the two main data that convinced the authorities to act, even if with an incredible late.